Clinical Trial Update: Use of Pulsatile Intravenous FSH to Mitigate Reprometabolic Syndrome [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is exploring pulsatile intravenous follicle-stimulating hormone (FSH) to mitigate reprometabolic syndrome, with recruitment ongoing for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility
• Obesity

Drugs mentioned

• follicle-stimulating hormone (follicle-stimulating hormone)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Infertility, Obesity | Phase 1 | Status: RECRUITING